Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

1.

The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.

Wang ZJ, Hu WK, Liu YY, Shi DM, Cheng WJ, Guo YH, Yang Q, Zhao YX, Zhou YJ.

Can J Cardiol. 2014 Jan;30(1):96-101. doi: 10.1016/j.cjca.2013.08.018.

PMID:
24365194
[PubMed - indexed for MEDLINE]
2.

Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.

Niccoli G, Sgueglia GA, Latib A, Crea F, Colombo A; CACTUS Study Group.

Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E37-44. doi: 10.1002/ccd.25102. Epub 2013 Aug 5.

PMID:
23813627
[PubMed - indexed for MEDLINE]
3.

Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.

Briguori C, Colombo A, Airoldi F, Violante A, Focaccio A, Balestrieri P, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Bonizzoni E, Ricciardelli B.

Eur Heart J. 2004 Oct;25(20):1822-8.

PMID:
15474697
[PubMed - indexed for MEDLINE]
Free Article
4.

Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.

Gordin J, Haider A, Swaminathan RV, Kim LK, Minutello RM, Bergman G, Wong SC, Feldman DN.

Am J Cardiol. 2012 Nov 15;110(10):1397-404. doi: 10.1016/j.amjcard.2012.06.052. Epub 2012 Aug 2.

PMID:
22858186
[PubMed - indexed for MEDLINE]
5.

Vitamin C and percutaneous coronary intervention: some answers, more questions.

Gebhard C, Tardif JC.

Can J Cardiol. 2014 Jan;30(1):3-5. doi: 10.1016/j.cjca.2013.10.018. Epub 2013 Nov 1. No abstract available.

PMID:
24365188
[PubMed - indexed for MEDLINE]
6.

Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.

Balian V, Galli M, Marcassa C, Cecchin G, Child M, Barlocco F, Petrucci E, Filippini G, Michi R, Onofri M.

Circulation. 2006 Oct 31;114(18):1948-54. Epub 2006 Oct 23.

PMID:
17060382
[PubMed - indexed for MEDLINE]
Free Article
7.

Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers.

Basili S, Tanzilli G, Mangieri E, Raparelli V, Di Santo S, Pignatelli P, Violi F.

JACC Cardiovasc Interv. 2010 Feb;3(2):221-9. doi: 10.1016/j.jcin.2009.10.025.

PMID:
20170881
[PubMed - indexed for MEDLINE]
Free Article
8.

Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.

Lindsey JB, Kennedy KF, Stolker JM, Gilchrist IC, Mukherjee D, Marso SP, Pencina MJ, Kleiman NS, Cohen DJ.

Circ Cardiovasc Interv. 2011 Oct 1;4(5):474-80. doi: 10.1161/CIRCINTERVENTIONS.111.962233. Epub 2011 Oct 4.

PMID:
21972402
[PubMed - indexed for MEDLINE]
Free Article
9.

Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.

Briguori C, Visconti G, Focaccio A, Golia B, Chieffo A, Castelli A, Mussardo M, Montorfano M, Ricciardelli B, Colombo A.

J Am Coll Cardiol. 2009 Dec 1;54(23):2157-63. doi: 10.1016/j.jacc.2009.07.005. Epub 2009 Aug 6.

PMID:
19664895
[PubMed - indexed for MEDLINE]
Free Article
10.

Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.

Veselka J, Zemánek D, Hájek P, Malý M, Adlová R, Martinkovicová L, Tesar D.

Am J Cardiol. 2009 Sep 1;104(5):630-3. doi: 10.1016/j.amjcard.2009.04.048. Epub 2009 Jun 24.

PMID:
19699335
[PubMed - indexed for MEDLINE]
11.

Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention.

Ang L, Thani KB, Ilapakurti M, Lee MS, Palakodeti V, Mahmud E.

J Am Coll Cardiol. 2013 Jan 8;61(1):23-34. doi: 10.1016/j.jacc.2012.09.037.

PMID:
23287370
[PubMed - indexed for MEDLINE]
Free Article
12.

A study comparing the incidence and predictors of creatine kinase MB and troponin T release after coronary angioplasty. Does Clopidogrel preloading reduce myocardial necrosis following elective percutaneous coronary intervention?

Moore RK, Lowe R, Grayson AD, Morris JL, Perry RA, Stables RH.

Int J Cardiol. 2007 Mar 2;116(1):93-7. Epub 2006 Jul 25.

PMID:
16870281
[PubMed - indexed for MEDLINE]
13.

Is periprocedural CK-MB a better indicator of prognosis after emergency and elective percutaneous coronary intervention compared with post-procedural cardiac troponins?

Gollop ND, Dhullipala A, Nagrath N, Myint PK.

Interact Cardiovasc Thorac Surg. 2013 Nov;17(5):867-71. doi: 10.1093/icvts/ivt303. Epub 2013 Jul 9. Review.

PMID:
23842761
[PubMed - indexed for MEDLINE]
Free Article
14.

With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.

Lim CC, van Gaal WJ, Testa L, Cuculi F, Arnold JR, Karamitsos T, Francis JM, Petersen SE, Digby JE, Westaby S, Antoniades C, Kharbanda RK, Burrell LM, Neubauer S, Banning AP.

J Am Coll Cardiol. 2011 Feb 8;57(6):653-61. doi: 10.1016/j.jacc.2010.07.058.

PMID:
21292125
[PubMed - indexed for MEDLINE]
Free Article
15.

Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.

Hwang J, Lee HC, Kim BW, Yang MJ, Park JS, Park JH, Lee HW, Oh J, Choi JH, Cha KS, Hong TJ, Song S, Kim SP.

J Cardiol. 2013 Aug;62(2):77-81. doi: 10.1016/j.jjcc.2013.03.017. Epub 2013 Jun 2.

PMID:
23731922
[PubMed - indexed for MEDLINE]
Free Article
16.

Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.

Chu-fan L, Xing W, Xun H, Gui-fu W, Cheng-heng H, Zhi-min D.

J Cardiovasc Med (Hagerstown). 2011 Nov;12(11):790-4. doi: 10.2459/JCM.0b013e32834bb47c.

PMID:
21934521
[PubMed - indexed for MEDLINE]
17.

Effects of intravenous N-acetylcysteine on periprocedural myocardial injury after on-pump coronary artery by-pass grafting.

Peker O, Peker T, Erdogan D, Ozaydin M, Kapan S, Sutcu R, Ibrisim E.

J Cardiovasc Surg (Torino). 2008 Aug;49(4):527-31.

PMID:
18665117
[PubMed - indexed for MEDLINE]
18.

Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial).

De Luca G, Iorio S, Venegoni L, Marino P.

Am J Cardiol. 2012 Jan 15;109(2):202-7. doi: 10.1016/j.amjcard.2011.08.027. Epub 2011 Oct 14.

PMID:
22000773
[PubMed - indexed for MEDLINE]
19.

Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery.

Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G, Engoren M, Alexander JH, Levy JH, Chaitman BR, Broderick S, Mack MJ, Pieper KS, Farkouh ME.

JAMA. 2011 Feb 9;305(6):585-91. doi: 10.1001/jama.2011.99.

PMID:
21304084
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk